Healthcare / Health Information ServicesTokyo
$2082.00
+60.00 (+2.97%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $5.6B · quality 70.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
60/100
B
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$170.9B
P/E
29.3x
↑EV/EBITDA
14.0x
↑ROE
12.8%
↑Gross Margin
88.4%
↑Debt/Equity
0.17
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+16.1%
FCF CAGR
-39.4%
FCF margin
2.8%
FCF / Net income
0.29x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $60.95B · net income $6.05B · FCF $1.74B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $60.95B | $60.95B | $53.97B | $45.67B | $38.90B |
| Net Income | $6.05B | $6.05B | $7.23B | $6.41B | $5.41B |
| EBITDA | $12.14B | $12.14B | $13.26B | $11.76B | $10.27B |
| EPS | 70.95 | 70.95 | 82.75 | 73.13 | 61.77 |
| Gross Margin | 88.4% | 88.4% | 88.1% | 87.8% | 88.5% |
| Operating Margin | 10.4% | 10.4% | 15.3% | 15.9% | 16.2% |
| Net Margin | 9.9% | 9.9% | 13.4% | 14.0% | 13.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.17 | 0.17 | 0.15 | 0.22 | 0.35 |
| Current Ratio | 1.56 | 1.56 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.74B | $1.74B | $6.06B | $5.59B | $7.81B |
| Returns | |||||
| ROE | 12.8% | 12.8% | 16.3% | 16.7% | 18.0% |
| Valuation | |||||
| P/E | 29.34 | 29.34 | 29.61 | 42.25 | 56.10 |
| EV/EBITDA | 13.96 | 13.96 | 15.24 | 22.28 | 29.13 |
| P/B | 3.75 | 3.75 | 4.83 | 7.05 | 10.12 |
| Growth & Yield | |||||
| Revenue Growth | 12.9% | 12.9% | 18.2% | 17.4% | — |
| EPS Growth | -14.3% | -14.3% | 13.2% | 18.4% | — |
| Dividend Yield | 1.5% | 1.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
37.6%
EPS terminal req.
$184.74
Spread vs growth
-51.8%
5Y implied EPS CAGR
25.8%
EPS terminal req.
$223.54
Spread vs growth
-40.1%
10Y implied EPS CAGR
17.6%
EPS terminal req.
$360.01
Spread vs growth
-31.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+50.0%
Start / end P/E
16.9x → 29.3x
EPS bridge
82.75 → 70.95
Residual
-10.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.